Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY19 is not expected to be complete until June, 2020.

  1. Mobility Life: Monitoring Mobility in Daily Lives of People with Neurological Disease

    SBC: APDM, INC.            Topic: NIA

    Project Summary Falls are the leading cause of injurieshospital visitsnursing home admissionsand reduced quality of life for people with neurological disordersAlthough there is consensus that impaired mobility is the basis for most fallsit is very di cult to evaluate these complex abilities outside a laboratory settingBrief clinical examinations do not accurately re ect dailyfunctional mobility in ...

    SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
  2. Using an API to commercialize an evidence based weight loss intervention

    SBC: COEUS HEALTH, LLC            Topic: 300

    DESCRIPTION provided by applicant Over percent of the U S population is currently overweight or obese percent are obese Obesity is a primary cause of numerous chronic diseases including type II diabetes cancer heart disease and the metabolic syndrome Behavioral weight loss interventions have successfully resulted in significant clinical improvements in weight percent weight lo ...

    SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
  3. A Cytomegalovirus based therapeutic vaccine against oncogenic human papillomaviruses

    SBC: TOMEGAVAX, INC.            Topic: 102

    Abstract High risk human papillomaviruses HPV cause cervical cancer the second most common neoplasm among women globally and a large proportion of oropharyngeal cancers Although prophylactic vaccines to HPV are effective they have no therapeutic effect and thus do not benefit the millions of individuals already infected Thus there is both a medical need and a commercial opportunity for a HP ...

    SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
  4. Identifying activators of interferon regulatory factors for neuroprotection

    SBC: Neuralexo, LLC            Topic: 106

    Abstract Stroke is a leading cause of morbidity and mortality in the United States However less than of patients are eligible for the current approved interventions of tissue plasminogen activator or thrombectomy We seek to develop new therapeutics to reduce the extent of damage and functional impairment resulting from ischemic injury to the brain an area of significant unmet medical need ...

    STTR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
  5. Newborn Infant Vision Test

    SBC: Precision Vision, Inc.            Topic: N

    Project Summary! This STTR Phase II project continues the development of the Newborn Acuity Cardstm and the Newborn Contrast Cardstm Together these Newborn Cards form a new clinical test of visual acuity and contrast sensi tivity for use on newborn full term and preterm infants The stimuli are square wave gratings which the examiner presents to the infant in a fixation and following protocol ...

    STTR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
  6. Aminomethyl benzamides as novel anti Ebola agents

    SBC: Chicago Biosolutions, Inc.            Topic: NIAID

    Ebola EBOV and Marburg MARV viruses belong to the family Filoviridae and can cause fatal hemorrhagic fevers characterized by widespread tissue destruction with an incubation period of days Because of the safety concerns these viruses are designated as the biosafety level agents Currently there is no effective vaccine or therapeutic treatment against filoviral infection and pathogenes ...

    STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  7. Better Living After Stroke through Technology BLAST

    SBC: BRIGHTOUTCOME INC.            Topic: 600

    DESCRIPTION provided by applicant Stroke the leading cause of disability cognitive impairment and death in the US imposes significant financial and personal burden The residual effects of stroke affect many aspects of life not addressed by traditional rehabilitation treatments In particular persons with mild stroke typically defined as a stroke with no or sligh motor impairment and a high ...

    SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
  8. Development and Commercialization of an Innovative Rapid HIV Incidence Assay

    SBC: SEDIA BIOSCIENCES CORPORATION            Topic: NIAID

    DESCRIPTION provided by applicant The objective of this Phase II project is to develop a commercially viable point of care Rapid HIV Incidence Assay the Asant Rapid HIV Recency Assay and establish its suitability for determination of recency of HIV infection in whole blood plasma serum specimens for epidemiological research and surveillance purposes from liquid blood serum or plasm ...

    SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
  9. Advanced Bicycle Helmet Technology for Prevention of Traumatic Brain Injury

    SBC: APEX BIOMEDICAL COMPANY, LLC            Topic: 106

    Traumatic brain injury TBI is an acquired neurological disorder that can cause long lasting disability with limited treatment options Therefore preventative strategies must be emphasized in high risk activities to reduce the individual and societal burden of this pervasive injury Bicycle activities account for of all sports related TBI with over annual injuries in the US In an e ...

    SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  10. Aminopiperidines as novel anti influenza agents

    SBC: Chicago Biosolutions, Inc.            Topic: NIAID

    Influenza A viruses belong to the orthomyxoviridae family with a negative sense segmented RNA genome which can cause seasonal or pandemic flu with high morbidity and significant mortality Vaccination is the most prevalent prophylactic means for controlling influenza infections However an effective vaccine usually takes at least months to develop for the circulating strains Furthermore vac ...

    STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government